Nanobiotix Valuation
| NANO Stock | EUR 5.70 0.81 12.44% |
At this time, the firm appears to be fairly valued. Nanobiotix SA secures a last-minute Real Value of €5.85 per share. The latest price of the firm is €5.7. Our model forecasts the value of Nanobiotix SA from analyzing the firm fundamentals such as Shares Outstanding of 34.88 M, operating margin of (17.96) %, and Return On Equity of -1.99 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Nanobiotix's price fluctuation is slightly risky at this time. Calculation of the real value of Nanobiotix SA is based on 3 months time horizon. Increasing Nanobiotix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nanobiotix SA is useful when determining the fair value of the Nanobiotix stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nanobiotix. Since Nanobiotix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nanobiotix Stock. However, Nanobiotix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.7 | Real 5.85 | Hype 5.7 | Naive 5.48 |
The real value of Nanobiotix Stock, also known as its intrinsic value, is the underlying worth of Nanobiotix SA Company, which is reflected in its stock price. It is based on Nanobiotix's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Nanobiotix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nanobiotix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nanobiotix SA helps investors to forecast how Nanobiotix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nanobiotix more accurately as focusing exclusively on Nanobiotix's fundamentals will not take into account other important factors: Nanobiotix Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Nanobiotix's current stock value. Our valuation model uses many indicators to compare Nanobiotix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanobiotix competition to find correlations between indicators driving Nanobiotix's intrinsic value. More Info.Nanobiotix SA is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanobiotix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanobiotix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanobiotix's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nanobiotix's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nanobiotix and how it compares across the competition.
About Nanobiotix Valuation
The stock valuation mechanism determines the current worth of Nanobiotix SA on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nanobiotix SA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nanobiotix SA based exclusively on its fundamental and basic technical indicators. By analyzing Nanobiotix's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nanobiotix's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nanobiotix. We calculate exposure to Nanobiotix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nanobiotix's related companies.Nanobiotix SA, a late stage clinical company, develops and sells nanomedicine for the treatment of cancer worldwide. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France. NANOBIOTIX operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 102 people.
8 Steps to conduct Nanobiotix's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nanobiotix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nanobiotix's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nanobiotix's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nanobiotix's revenue streams: Identify Nanobiotix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nanobiotix's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nanobiotix's growth potential: Evaluate Nanobiotix's management, business model, and growth potential.
- Determine Nanobiotix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nanobiotix's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobiotix SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |